Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01273597 · OUTCOME

Number of Participants With Hypercalcaemia During Preceding 6 Months of Conventional Vitamin D Therapy

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands · Source last updated 2013-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
6 months prior to start of study through baseline

What was measured

Hypercalcaemia (serum calcium \> 2.6 mmol/L) among participants during the preceding 6 months of conventional vitamin D therapy was derived from retrospective data collection in case report form, reported at baseline. Conventional vitamin D therapy included vitamin D supplement products from ATC group A11CC (vitamin D and analogues).

Analysis population: Participants with available retrospective data

Groups in this outcome

End-stage Kidney Disease With Secondary Hyperparathyroidism

Participants with chronic kidney disease (CKD) stage 5 receiving haemodialysis with a diagnosis of secondary hyperparathyroidism (SHPT)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
End-stage Kidney Disease With Secondary Hyperparathyroidism58

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
End-stage Kidney Disease With Secondary Hyperparathyroidism5Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
denoms
  1. counts
    1. group Id
      OG000
      value
      58
    units
    Participants
description
Hypercalcaemia (serum calcium \> 2.6 mmol/L) among participants during the preceding 6 months of conventional vitamin D therapy was derived from retrospective data collection in case report form, reported at baseline. Conventional vitamin D therapy included vitamin D supplement products from ATC group A11CC (vitamin D and analogues).
groups
  1. description
    Participants with chronic kidney disease (CKD) stage 5 receiving haemodialysis with a diagnosis of secondary hyperparathyroidism (SHPT)
    id
    OG000
    title
    End-stage Kidney Disease With Secondary Hyperparathyroidism
param Type
NUMBER
population Description
Participants with available retrospective data
reporting Status
POSTED
time Frame
6 months prior to start of study through baseline
title
Number of Participants With Hypercalcaemia During Preceding 6 Months of Conventional Vitamin D Therapy
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice